• 1
    Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM 1983 Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:10001006.
  • 2
    Bauer E, Aub J, Albright JF 1929 Studies of calcium and phosphorus metabolism: Study of bone trabeculae as readily available reserve supply of calcium. J Exp Med 49:145162.
  • 3
    Rubin MR, Cosman F, Lindsay R, Bilezikian JP 2002 The anabolic effects of parathyroid hormone. Osteoporos Int 13:267277.
  • 4
    Turner CH 2002 Biomechanics of bone: Determinants of skeletal fragility and bone quality. Osteoporos Int 13:97104.
  • 5
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:14341441.
  • 6
    Hodsman AB, Steer BM, Fraher LJ, Drost DJ 1991 Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patients. Bone Miner 14:6783.
  • 7
    Reeve J, Bradbeer JN, Arlot M, Davies UM, Green JR, Hampton L, Edouard C, Hesp R, Hulme P, Ashby JP 1991 hPTH 1–34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses. Osteoporos Int 1:162170.
  • 8
    Slovik DM, Rosenthal DI, Doppelt SH, Potts JT Jr, Daly MA, Campbell JA, Neer RM 1986 Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1:377381.
  • 9
    Finkelstein JS, Klibanski A, Arnold AL, Toth TL, Hornstein MD, Neer RM 1998 Prevention of estrogen deficiency-related bone loss with human parathyroid hormone (1–34): A randomized controlled trial. JAMA 280:10671073.
  • 10
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D 1997 A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 82:620628.
  • 11
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD 1998 Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:16271633.
  • 12
    Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F 1997 Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550555.
  • 13
    Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT Jr 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial. BMJ 280:13401344.
  • 14
    Bradbeer JN, Arlot ME, Meunier PJ, Reeve J 1992 Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: Increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone. Clin Endocrinol (Oxf) 37:282289.
  • 15
    Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH 2000 Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1–34) therapy in women with severe osteoporosis. Bone 27:311318.
  • 16
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16:18461853.
  • 17
    Vogel M, Hesch RD, Delling G 1990 Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1–38 hPTH) and sequential addition of calcitonin nasal spray. Med Klin 85:8286.
  • 18
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595610.
  • 19
    Jiang Y, Zhao J, Genant HK 2002 Macro and micro imaging of bone architecture. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology, 2nd ed. Academic Press, San Diego, CA, USA, pp. 15991623.
  • 20
    Eriksen EF 1986 Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 7:379408.
  • 21
    Jiang Y, Zhao J, White JL, Genant HK 2000 Micro CT and micro MR imaging of the 3D architecture of animal skeleton. J Musculoskeletal Neuronal Interactions 1:4551.
  • 22
    Goulet RW, Goldstein SA, Ciarelli MJ, Kuhn JL, Brown MB, Feldkamp LA 1994 The relationship between the structural and orthogonal compressive properties of trabecular bone. J Biomech 27:375389.
  • 23
    Muller R, Hildebrand T, Ruegsegger P 1994 Non-invasive bone biopsy: A new method to analyze and display the three-dimensional structure of trabecular bone. Phys Med Biol 39:145164.
  • 24
    Mashiba T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 2001 Effects of human parathyroid hormone (1–34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. Bone 28:538547.
  • 25
    Turner RT, Evans GL, Cavolina JM, Halloran B, Morey-Holton E 1998 Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats. Endocrinology 139:40864091.
  • 26
    Jiang Y, Zhao J, Van Audekercke R, Dequeker J, Geusens P 1996 Effects of low-dose long-term sodium fluoride preventive treatment on rat bone mass and biomechanical properties. Calcif Tissue Int 58:3039.
  • 27
    Horwitz M, Stewart A, Greenspan SL 2000 Sequential parathyroid hormone/alendronate therapy for osteoporosis—robbing Peter to pay Paul? J Clin Endocrinol Metab 85:21272128.
  • 28
    Neer M, Slovik DM, Daly M, Potts T Jr, Nussbaum SR 1993 Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3(Suppl 1):204205.
  • 29
    Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 1999 Anabolic effects of human biosynthetic parathyroid hormone fragment (1–34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536545.
  • 30
    Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM 2001 Intermittently administered human parathyroid hormone (1–34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16:157165.
  • 31
    Zanchetta JR, Bogado C, Ferretti JL, Wang O, Sato M, Gaich GA 2002 Effects of ly 333334 [recombinant human parathyroid hormone (1–34)] on cortical bone strength indices as assessed by peripheral quantitative computed tomography. Bone 28:S86.
  • 32
    Hyldstrup L, Jorgensen JT, Gaich G 2002 Assessment of effects of ly333334 [recombinant human parathyroid hormone (1–34)] on cortical bone using digital x-ray radiogrammetry. Bone 28:S97.
  • 33
    Uusi-Rasi K, Beck TJ, Oreskovic TL, Sato M, Bogado CE, Zanchetta JR 2002 Teriparatide [rhPTH(1–34)] improves the structural geometry of the hip. J Bone Miner Res 17:S208.
  • 34
    Rockoff SD, Sweet E, Bleustein J 1969 The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res 3:163175.
  • 35
    Faulkner KG, Cann CE, Hasegawa BH 1991 Effect of bone distribution on vertebral strength: Assessment with patient-specific nonlinear finite element analysis. Radiology 179:669674.
  • 36
    Ejersted C, Andreassen TT, Nilsson MH, Oxlund H 1994 Human parathyroid hormone (1–34) increases bone formation and strength of cortical bone in aged rats. Eur J Endocrinol 130:201207.
  • 37
    Sogaard CH, Wronski TJ, McOsker JE, Mosekilde L 1994 The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates. Endocrinology 134:650657.
  • 38
    Sato M, Zeng GQ, Turner CH 1997 Biosynthetic human parathyroid hormone (1–34) effects on bone quality in aged ovariectomized rats. Endocrinology 138:43304337.
  • 39
    Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R 2001 Treatment with human parathyroid hormone (1–34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150159.
  • 40
    Parisien M, Cosman F, Mellish RW, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP 1995 Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 10:13931399.
  • 41
    Boyce RW, Ebert DC, Youngs TA, Paddock CL, Mosekilde L, Stevens ML, Gundersen HJ 1995 Unbiased estimation of vertebral trabecular connectivity in calcium-restricted ovariectomized minipigs. Bone 16:637642.
  • 42
    Boyce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF 1996 Effects of intermittent hPTH(1–34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11:600613.
  • 43
    Boyce RW, Wronski TJ, Ebert DC, Stevens ML, Paddock CL, Youngs TA, Gundersen HJ 1995 Direct stereological estimation of three-dimensional connectivity in rat vertebrae: Effect of estrogen, etidronate and risedronate following ovariectomy. Bone 16:209213.
  • 44
    Parisien MV, McMahon D, Pushparaj N, Dempster DW 1988 Trabecular architecture in iliac crest bone biopsies: Infra-individual variability in structural parameters and changes with age. Bone 9:289295.
  • 45
    Johnston CC, Norton J, Khairi MR, Kernek C, Edouard C, Arlot M, Meunier PJ 1985 Heterogeneity of fracture syndromes in postmenopausal women. J Clin Endocrinol Metab 61:551556.
  • 46
    Parfitt AM 1984 Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical consequences. Calcif Tissue Int 36(Suppl 1):S123S128.
  • 47
    Jiang Y, Zhao J, Augat P, Ouyang X, Lu Y, Majumdar S, Genant HK 1998 Trabecular bone mineral and calculated structure of human bone specimens scanned by peripheral quantitative computed tomography: Relation to biomechanical properties. J Bone Miner Res 13:17831790.
  • 48
    Borah B, Dufresne TE, Cockman MD, Gross GJ, Sod EW, Myers WR, Combs KS, Higgins RE, Pierce SA, Stevens ML 2000 Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling. J Bone Miner Res 15:17861797.
  • 49
    Zhao J, Jiang Y, Prevrhal S, Genant HK 2000 Effects of low dose long-term sodium fluoride on three-dimensional trabecular microstructure, bone mineral, and biomechanical properties of rat body. J Bone Miner Res 15:816.
  • 50
    Sato M, Westmore M, Clendenon J, Smith S, Hannum B, Zeng GQ, Brommage R, Turner CH 2000 Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques. Osteoporos Int 11:871880.